These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10678345)

  • 41. Management of the behavioral manifestations of dementia.
    Yeager BF; Farnett LE; Ruzicka SA
    Arch Intern Med; 1995 Feb; 155(3):250-60. PubMed ID: 7832596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument.
    Ballard C; Cream J
    Int Psychogeriatr; 2005 Mar; 17(1):4-12; discussion 22-9. PubMed ID: 15945588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Licensed indication for risperidone in dementia.
    Phizackerley D
    BMJ; 2014 Dec; 349():g7337. PubMed ID: 25498536
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of norepinephrine in the behavioral and psychological symptoms of dementia.
    Herrmann N; Lanctôt KL; Khan LR
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):261-76. PubMed ID: 15377733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.
    Smith DA; Beier MT
    J Am Med Dir Assoc; 2004; 5(2):129-32. PubMed ID: 15008183
    [No Abstract]   [Full Text] [Related]  

  • 46. Antipsychotic drugs for aggression in intellectual disability.
    Matson JL; Wilkins J
    Lancet; 2008 Jan; 371(9606):9-10. PubMed ID: 18177758
    [No Abstract]   [Full Text] [Related]  

  • 47. Can risperidone be antidepressive and also inhibit aggression?
    Bernhard R
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):627-8. PubMed ID: 9447511
    [No Abstract]   [Full Text] [Related]  

  • 48. [Atypical antipsychotic drugs: heroes or villains? A clinical perspective].
    Alvarez-Fernández B
    An Med Interna; 2007 Sep; 24(9):453-5. PubMed ID: 18198956
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacotherapy of aggression].
    Pöldinger W
    Schweiz Arch Neurol Neurochir Psychiatr; 1981; 129(1):147-55. PubMed ID: 6118948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone guidelines.
    Klausner M; Brecher M
    Psychiatr Serv; 1995 Sep; 46(9):950-1. PubMed ID: 7583512
    [No Abstract]   [Full Text] [Related]  

  • 51. Behavioral Disturbances in Dementia and Beyond: Time for a New Conceptual Frame?
    Ambrogio F; Martella LA; Odetti P; Monacelli F
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.
    Lanctôt KL; Best TS; Mittmann N; Liu BA; Oh PI; Einarson TR; Naranjo CA
    J Clin Psychiatry; 1998 Oct; 59(10):550-61; quiz 562-3. PubMed ID: 9818639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrovascular events after treatment of dementia patients with risperidone.
    Wancata J
    Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of Diogenes syndrome: clinical and ethical challenges.
    Bonci G; Varghese E; Mahgoub N
    J Am Geriatr Soc; 2012 Sep; 60(9):1780-1. PubMed ID: 22985153
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to "Risperidone and sulpiride: Brands vs generics".
    Hsu CW; Lee SY; Wang LJ
    Schizophr Res; 2018 May; 195():274. PubMed ID: 28844637
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neuroleptics: value and indications].
    Dupuy C
    Soins; 1994 Dec-1995 Jan; (591-592):49-50. PubMed ID: 7652607
    [No Abstract]   [Full Text] [Related]  

  • 57. [Neuroleptics in geronto-psychiatry : their use, and precautions for use].
    Peron M
    Ann Med Psychol (Paris); 1979; 137(3-4):356-60. PubMed ID: 40515
    [No Abstract]   [Full Text] [Related]  

  • 58. Nadolol in the treatment of aggression in chronic psychiatric inpatients.
    Wong MK; Lee S
    J Clin Psychiatry; 1993 Jun; 54(6):235. PubMed ID: 8331093
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs for disruptive features in dementia.
    Drug Ther Bull; 2003 Jan; 41(1):1-4. PubMed ID: 12611356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dementia: diagnosis and emergency behavioral complications.
    Tueth MJ
    J Emerg Med; 1995; 13(4):519-25. PubMed ID: 7594373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.